Nicox and Vester Finance: Partnership to Support Strategic Initiatives

Nicox SA announces the signing of a shareholder current account advance agreement with Vester Finance. This partnership allows Nicox to access potential financing of €6 million over three years, with no obligation to draw down the funds. This flexibility aims to support the strategic initiatives of the ophthalmology-specializing company. The advances can be repaid in shares or cash, with a maximum dilution of 16% of the share capital in the event of full repayment in shares.

The company anticipates that its operating costs will be covered beyond 2027, thanks to recurring revenue from the NCX 470. The application for approval of this product is expected to be filed this summer. This financing provides additional, non-binding support for Nicox. The agreement, set at 7% annual interest, offers early redemption options at Nicox's discretion. By using this structure, Nicox remains flexible to future opportunities, while Vester could hold up to 14.5% of the equity in the event of full drawdown.